Richartz et al v. Boehringer Ingelheim Pharmaceuticals, Inc. et al

Docket(#10) ORDER Dismissing Case With Prejudice. Granting 6945 Defendant's MOTION to Dismiss with Prejudice 6642 Order Brand Defendants Consolidated MOTION in Response to PTO 84, filed in case 20-md-2924. Cases 3:23-cv-23061, 3:23-cv-23062, 3:23-cv-23063, 3:23-cv-23064, 3:23-cv-23065, 3:23-cv-23066, 3:23-cv-23067, 3:23-cv-23068, 3:23-cv-23069, 3:23-cv-23070, 23-cv-23071, 3:23-cv-23076, 23-cv-23077, 3:23-cv-23084, 3:23-cv-23085, 3:23-cv-23088, 3:23-cv-23089, 3:23-cv-23090, 3:23-cv-23091, 3:23-cv-81118, 9:23-cv-81121, 9:23-cv-81122, 3:23-cv-23056, 3:23-cv-80956 are all Dismissed with Prejudice. Signed by Judge Robin L. Rosenberg on 9/19/2023. See attached document for full details. (jas) (Entered: 09/20/2023)

Docket(#9) ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. The above-styled cases, 23-cv-81118, 23-cv-81121, and 23-cv-81122 are consolidated in MDL proceeding 20-MD-2924 for all pretrial purposes, and the parties are directed to submit all filings in the MDL action. 23-cv-81118, 23-cv-81121, and 23-cv-81122 are Administratively Closed. Signed by Judge Robin L. Rosenberg on 8/22/2023. See attached document for full details. (jas) (Entered: 08/22/2023)

Docket(#8) MDL Transfer In Case Receipt from District of District of New Jersey. Case Number 3:23-cv-03584 with documents 1-5. Assigned FLSD Case Number 23-cv-81118. Re: FLSD MDL Case Number 20-md-2924. Clerks Note: JPML notified. (jas) (Entered: 08/04/2023)

Docket(#7) Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Bruce E. Reinhart. (jas) (Entered: 08/04/2023)

Docket(#6) Case transferred in from New Jersey; Case Number 3:23-cv-03584. Electronic file including transfer order and docket sheet received. .(jas). (Entered: 08/04/2023)

Docket(#5) Order of MDL Panel (CTO-118) transferring case to the Southern District of Florida. (jjc, ) (Entered: 08/04/2023)

Docket(#4) NOTICE of Appearance by VINCENT CHENG on behalf of All Plaintiffs (CHENG, VINCENT) (Entered: 07/24/2023)

DocketCLERK'S QUALITY CONTROL MESSAGE - The case you electronically filed has been processed, however, the following deficiencies were found: All defendants were not added to the docket. When entering parties make sure to add ALL PLAINTIFFS AND DEFENDANTS as found on the original state court complaint. The Clerk's Office has made the appropriate changes. Please refer to the Attorney Case Opening Guide for processing electronically filed cases. (jjc, ) (Entered: 07/06/2023)

DocketCLERK'S QUALITY CONTROL MESSAGE - Please be advised, pursuant to Fed. R. Civ. P. 7.1, a disclosure statement is required to be filed by parties and intervenors in diversity actions to identify the citizenship of every individual or entity whose citizenship is attributed to that party or intervenor. Such disclosure statements must be filed with the parties, intervenors or proposed intervenors first appearance, pleading, petition, motion, response or other request addressed to the Court. (kht) (Entered: 07/06/2023)

DocketJudge Michael A. Shipp and Magistrate Judge Douglas E. Arpert added. (kht) (Entered: 07/06/2023)

Docket(#3) NOTICE of Appearance by TIMOTHY IGNATIUS DUFFY on behalf of BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation (DUFFY, TIMOTHY) (Entered: 07/05/2023)

Docket(#2) Corporate Disclosure Statement by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (SILVER, MARK) (Entered: 07/05/2023)

Docket(#1) NOTICE OF REMOVAL by Boehringer Ingelheim Corporation, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim USA Corporation from Superior Court of New Jersey, Middlesex County, case number MID-L-005126-22. ( Filing and Admin fee $ 402 receipt number ANJDC-14431501), filed by Boehringer Ingelheim Corporation, BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Boehringer Ingelheim USA Corporation. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3 - Part 1, #4 Exhibit 3 - Part 2, #5 Exhibit 3 - Part 3, #6 Exhibit 3 - Part 4, #7 Exhibit 3 - Part 5, #8 Civil Cover Sheet)(SILVER, MARK) (Entered: 07/05/2023)